Newsroom
To Get in Touch with DLC:
Media (@) Diabetes Leadership (DOT) org
Hot Topics
In The News
Release
INSULIN Act Gains Momentum with Bipartisan House Introduction
Letter
DLC and DPAC Respond to CMS Proposed Rule to Reiterate Patient Disruptions to come from the Competitive Bidding Program for CGMs and Insulin Pumps.
Letter
DLC and DPAC Respond to Senate HELP Committee's 340B Drug Pricing Integrity and Affordability for Patients Act Discussion Draft
Letter
Response to the Senate Finance Committee Minority Staff Request for Information, “Commonsense Policy Options to Lower Drug Prices for Patients”
Release
DLC and DPAC Applaud House Appropriations Committee for Acting to Protect Access to Lifesaving Diabetes Technology
Report
2026 DLC Annual Report
Release
INSULIN Act Introduced to ImproveAccess and Affordability of Insulin for People with Diabetes
Release
Diabetes Leadership Council and Diabetes Patient Advocacy Coalition Urge CMS to Enforce Court Decision on Copay Accumulator Policies in Response to Proposed Marketplace Regulation
Release
Sens. Shaheen & Collins Introduce Legislation to Improve Access to Diabetes Technology and Education for Medicare Beneficiaries
Release
DLC leads consensus statement on diabetes health care reform
Release
Diabetes Leadership Council and Diabetes Patient Advocacy Coalition: Our Advocacy Continues after Positive First Steps in PBM Reform
Release
DPAC and DLC Respond to Administration’s “Great Healthcare Plan” and Call for Urgent PBM Reform
Release
New Model to Expand Access to Obesity Treatments is a Positive Step Toward Better Obesity Care for Patients
Release
The Diabetes Leadership Council Announces 2026 Board of Directors
Release
DLC and DPAC: Patients will Be Negatively Impacted by Changes to CGM & Insulin Pump Delivery in Medicare
Diabetes Leadership Council Calls for Expanded Patient Choice in Diabetes Technologies to Improve Outcomes and Equity
DLC and DPAC Respond to Section 232 Investigation on Pharmaceuticals
Letter
DLC/DPAC Letter to HHS and NIH on the Importance of DPPOS Funding
Statements and Letters
Fast Facts
Policy Recommendations to Improve U.S. Health Care
Patient costs for medicines, equipment and supplies should reflect all discounts and rebates negotiated or mandated across the supply chain, just like other health care products and services. National level rebate reform is a critical step to help patients afford their medicines and confront perverse financial incentives in the current system.
Download Our Consensus Statement.png)

